Edition:
United States

Guangdong Taiantang Pharmaceutical Co Ltd (002433.SZ)

002433.SZ on Shenzhen Stock Exchange

10.88CNY
24 Mar 2017
Change (% chg)

¥0.01 (+0.09%)
Prev Close
¥10.87
Open
¥10.86
Day's High
¥10.88
Day's Low
¥10.77
Volume
7,888,070
Avg. Vol
8,835,108
52-wk High
¥11.91
52-wk Low
¥8.97

Latest Key Developments (Source: Significant Developments)

Guangdong Taiantang Pharmaceutical says 2016 net profit up 25 pct to 40 pct
Tuesday, 25 Oct 2016 09:59pm EDT 

Guangdong Taiantang Pharmaceutical Co., Ltd.<002433.SZ>: Sees net profit for 2016 to increase by 25 percent to 40 percent, or to be 237.7 million yuan to 266.2 million yuan . Says the net profit of 2015 was 190.1 million yuan .Comments that increase in Chinese patent medicine is the main reason for the forecast.  Full Article

Guangdong Taiantang Pharmaceutical cuts private placement size to 2.5 bln yuan
Tuesday, 16 Aug 2016 02:00am EDT 

Guangdong Taiantang Pharmaceutical Co Ltd <002433.SZ> :Says it cuts private placement size to 2.5 billion yuan from 2.8 billion yuan previously.  Full Article

Guangdong Taiantang Pharmaceutical to pay 2015 dividend on June 16
Tuesday, 7 Jun 2016 06:30am EDT 

Guangdong Taiantang Pharmaceutical Co Ltd <002433.SZ> : Says it plans to pay a cash dividend of 0.25 yuan (before tax) per share to shareholders of record on June 15, for 2015 .Says the company's shares will be traded ex-right and ex-dividend on June 16 and the dividend will be paid on June 16.  Full Article

Guangdong Taiantang Pharmaceutical issues H1 2016 net profit outlook
Tuesday, 26 Apr 2016 08:00pm EDT 

Guangdong Taiantang Pharmaceutical Co Ltd:Sees net profit for H1 2016 to increase by 10 pct to 30 pct, or to be 82,233,600 yuan to 97,185,100 yuan, compared to net profit of the same period in 2015 (74,757,800 yuan).Comments that increased sales of main business is the main reason for the outlook.  Full Article

Guangdong Taiantang Pharmaceutical announces 2015 dividend payment
Monday, 28 Mar 2016 08:00pm EDT 

Guangdong Taiantang Pharmaceutical Co Ltd:To (use undistributed profits to) pay cash dividend of 0.25 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

Guangdong Taiantang Pharmaceutical issues 2016 corporation bonds
Wednesday, 3 Feb 2016 07:00pm EST 

Guangdong Taiantang Pharmaceutical Co Ltd:Issues corporation bonds for 2016 worth 900 million yuan in total, each with par value and an issue price of 100 yuan.  Full Article

Guangdong Taiantang Pharmaceutical announces coupon rate of 2016 corporation bonds
Monday, 1 Feb 2016 07:00pm EST 

Guangdong Taiantang Pharmaceutical Co Ltd:To issue 2016 corporation bonds with coupon rate of 4.98 pct.  Full Article

Guangdong Taiantang Pharmaceutical to issue 2016 corporate bonds
Thursday, 28 Jan 2016 07:00pm EST 

Guangdong Taiantang Pharmaceutical Co Ltd:To issue up to 900 million yuan worth of unsecured corporate bonds for 2016, each with par value and an issue price of 100 yuan.Bonds will be with a term of five years and the interest will be paid on each Feb. 2 from 2017 to 2021, with coupon rate ranging from 4 pct to 5.5 pct.GF Securities Co., Ltd will serve as the main underwriter.  Full Article

Guangdong Taiantang Pharmaceutical revises 2015 net profit outlook
Friday, 22 Jan 2016 07:00pm EST 

Guangdong Taiantang Pharmaceutical Co Ltd:Sees net profit for 2015 to increase 10 pct to 30 pct, or to be 204.9376 million yuan to 242.1990 million yuan, compared to net profit of 2014 (186.3069 million yuan).In the previous outlook, the company expected the net profit for 2015 to be 214.2529 million yuan to 251.5143 million yuan.2015 reported net profit of 251.00 million yuan – Thomson Reuters I/B/E/S.Comments that larger input and increased management cost are the main reasons for the forecast.  Full Article

Tasly Pharmaceutical Group signs strategic cooperation framework agreement with Guangdong Taiantang Pharmaceutical Co Ltd
Thursday, 19 Nov 2015 07:00pm EST 

Tasly Pharmaceutical Group Co Ltd:Signs a strategic cooperation framework agreement with Guangdong Taiantang Pharmaceutical Co Ltd.The parties will cooperate in the Taiantang's product FDA certification in the United States, product marketing, equity investment field.  Full Article

More From Around the Web